The US Food and Drug Administration (FDA) has hit Philips with a warning letter after quality control shortcomings were uncovered at three of its medical device manufacturing sites.

The FDA’s regulations and expectations for medical devices are designed to ensure that benefits outweigh the risks. In three months, the U.S.

Shawpak presents a new range of low-power, low-waste linear thermoforming machines to produce large, multi-component packs with snap features for the medical sector.

The U.S. Food and Drug Administration has flagged three of Philips' medical device facilities after inspections found they ...

Investing.com -- Koninklijke Philips N.V. (NYSE:PHG) stock fell 8% after the U.S. Food and Drug Administration (FDA) issued a warning letter to the company regarding multiple violations found during ...

Stevanato Group S.p.A. continues expanding across global healthcare markets. The company strengthens its dual focus on biopharmaceutical solutions. Innovation and precision manufacturing support its ...

As healthcare systems work towards new sustainability goals, medical textiles have become a key focus for innovation.

The FDA has sent Philips a warning letter over three ultrasound and enterprise informatics facilities in the U.S. and the Netherlands.

The Director General of the National Agency for Food and Drug Administration and Control, NAFDAC, Prof. Mojisola Adeyeye, has expressed the hope that the nation would manufacture vaccines before she ...

In boardrooms across the globe, a fundamental shift is taking place. Regulatory compliance, once viewed as a back-office ...

Explore high-paying trade jobs that don't require a college degree. According to the Bureau of Labor Statistics, many offer ...